Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Diagnosis and Prognosis is Scopus-indexed (Q3, CiteScore 2.5). Published by International Institute of Anticancer Research.
Checked against the index lists dated .
ISSN 2732-7787Verify ISSN ↗
Publisher: International Institute of Anticancer Research
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 276 / 428 | 35th | Q3 |
| Cancer Research | 185 / 233 | 20th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q3, CiteScore 2.5.
Cancer Diagnosis and Prognosis is Q3 in Oncology (rank 276 of 428) and Q4 in Cancer Research (rank 185 of 233), by CiteScore 2025.
Cancer Diagnosis and Prognosis is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.5, quartile Q3, 35th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.438, quartile Q3, with an H-index of 14.
Cancer Diagnosis and Prognosis is published by International Institute of Anticancer Research. Its ISSN is 2732-7787.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cancer Diagnosis and Prognosis has an h-index of 18 and a 2-year mean of 1.53 citations per paper (OpenAlex). Its Scopus CiteScore is 2.5, quartile Q3. On 2-year citations it ranks #241 of 424 Scopus journals in Oncology.
Cancer Diagnosis and Prognosis published 97 papers in 2025; its busiest recent year was 2024 with 126. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from Japan (58.1%), United States (9.8%) and Türkiye (4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.